Actively Recruiting
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
Led by Poitiers University Hospital · Updated on 2026-03-11
90
Participants Needed
1
Research Sites
169 weeks
Total Duration
On this page
Sponsors
P
Poitiers University Hospital
Lead Sponsor
U
University of Poitiers
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.
CONDITIONS
Official Title
Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient consulting in routine care in one of the CMRR
- No sensory impairment that may compromise smartphone use
You will not qualify if you...
- Inability to perform MMSE or MMSE < 20
- Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
- Severe anxiety or depressive disorder HADS score 63; 17
- Terminal phase of a severe disease
- Evidence of a lesion on MRI that may be involved in cognitive impairment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Poitiers
Poitiers, France, 86000
Actively Recruiting
Research Team
A
Adrien JULIAN
CONTACT
R
RABOIS Emilie
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here